#therapies

- Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) has approved Optune in ...

based companion diagnostic (CDx) in immuno-oncologyDARMSTADT, Germany & NEW YORK--(Antara/BUSINESS WIRE.

- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it has sent a letter to Robert J. ...

-  The team of seven researchers from Malaysia, the Netherlands, Spain and the UK, including Professor Yasin Temel ...

- PneumRx, Inc. (www.pneumrx.com), a leader in the field of interventional pulmonology, today announced that it has ...

- The Bill & Melinda Gates Foundation today announced that it will commit $50 million to support the scale up of ...

Some 250 hospitals in Indonesia are preparing to introduce traditional and herbal treatments as an alternative to ...

- Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung ...

- The Peninsula Shanghai has been recognised as the world's top business hotel for the second consecutive year by ...

The world is losing the battle against diabetes as the number of people estimated to be living with the disease soars ...

- NeuroAiD, a stroke treatment based on Traditional Chinese Medicine, increases the odds of achieving a better ...

NANOBIOTIX (Euronext: NANO), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment ...

-Two-three day treatment provides clinically relevant, sustained clearance of AK after 12 monthsAn analysis of ...

-      LEO Pharma announces a co-creation agreement with the National Psoriasis Foundation ...

-     Virobay, Inc. and LEO Pharma A/S today announced that their collaboration on the development ...